【结 构 式】 |
【药物名称】 【化学名称】N-Benzyl-9-isopropyl-2-(thiomorpholin-4-yl)-9H-purin-6-amine 【CA登记号】 【 分 子 式 】C19H24N6S 【 分 子 量 】368.50733 |
【开发单位】LG Chem (Originator) 【药理作用】Oncolytic Drugs, CDK2 Inhibitors, Inhibitors of Signal Transduction Pathways |
合成路线1
Adenine (I) was oxidized with hydrogen peroxide in aqueous acetic acid to give adenine 1-N-oxide (II). Diazotization of (II) with sodium nitrite and acetic acid, followed by hydrolysis of the diazonium salt provided hypoxanthine 1-N-oxide (III). 2,6-Dichloropurine (IV) was then obtained by treatment of (III) with phosphoryl chloride in the presence of triethylamine. Displacement of the 6-chlorine atom of (IV) by benzylamine (V) in boiling n-butanol yielded 6-benzylamino-2-chloropurine (VI), which was subsequently alkylated at the 9-N with isopropyl iodide and NaH to give (VII). Finally, the remaining 2-chloro atom of (VII) was displaced by thiomorpholine (VIII) to furnish the title compound.
【1】 Woo, E.-R.; Baek, D.J.; Lee, s.-C.; Hong, C.Y.; Lee, K.-S.; Yang, B.-S.; Cho, J.-H.; Oh, C.-H.; Synthesis and biological activities of C-2, N-9 substituted 6-benzylaminopurine derivatives as cyclin-dependent kinase inhibitor. Arch Pharm 1999, 332, 6, 187. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 10343 | 9H-Purin-6-amine; 9H-Purin-6-ylamine; Adenine | 73-24-5 | C5H5N5 | 详情 | 详情 |
(II) | 36313 | 6-amino-9H-purin-1-ium-1-olate | C5H5N5O | 详情 | 详情 | |
(III) | 36314 | 6-hydroxy-9H-purin-1-ium-1-olate | C5H4N4O2 | 详情 | 详情 | |
(IV) | 25254 | 2,6-dichloro-9H-purine | 5451-40-1 | C5H2Cl2N4 | 详情 | 详情 |
(V) | 15147 | Benzylamine; Phenylmethanamine | 100-46-9 | C7H9N | 详情 | 详情 |
(VI) | 36315 | N-benzyl-2-chloro-9H-purin-6-amine; N-benzyl-N-(2-chloro-9H-purin-6-yl)amine | C12H10ClN5 | 详情 | 详情 | |
(VII) | 36316 | N-benzyl-2-chloro-9-isopropyl-9H-purin-6-amine; N-benzyl-N-(2-chloro-9-isopropyl-9H-purin-6-yl)amine | C15H16ClN5 | 详情 | 详情 | |
(VIII) | 36317 | thiomorpholine | 123-90-0 | C4H9NS | 详情 | 详情 |